Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 17;12(4):1117.
doi: 10.3390/nu12041117.

Irritable Bowel Syndrome and Gluten-Related Disorders

Affiliations

Irritable Bowel Syndrome and Gluten-Related Disorders

Paolo Usai-Satta et al. Nutrients. .

Abstract

Background: Irritable bowel syndrome (IBS) is frequently associated with celiac disease (CD) and nonceliac gluten/wheat sensitivity (NCGS/NCWS), but epidemiological and pathophysiological aspects are still unclear. Furthermore, a gluten-free diet (GFD) can positively influence IBS symptoms. Methods: A comprehensive online search for IBS related to CD, NCGS and GFD was made using the Pubmed, Medline and Cochrane databases. Results: Although a systematic screening for CD in IBS is not recommended, CD prevalence can be increased in diarrhea-predominant IBS patients. On the other hand, IBS symptoms can be persistent in treated CD patients, and their prevalence tends to decrease on a GFD. IBS symptoms may overlap and be similar to those associated to nonceliac gluten and/or wheat sensitivity. Increased gut permeability could explain the gluten/wheat effects in IBS patients. Finally, a GFD could improve symptoms in a subgroup of IBS patients. Conclusions: The possible interplay between IBS and gluten-related disorders represents a scientifically and clinically challenging issue. Further studies are needed to confirm these data and better clarify the involved pathophysiological mechanisms.

Keywords: celiac disease; gluten-free diet; irritable bowel syndrome; nonceliac gluten/wheat sensitivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ford A.C., Lacy B.E., Talley N.J. Irritable Bowel Syndrome. N. Engl. J. Med. 2017;376:2566–2578. doi: 10.1056/NEJMra1607547. - DOI - PubMed
    1. Hungin A.P.S., Whorwell P., Tack J., Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40 000 subjects. Aliment. Pharmacol. Ther. 2003;17:643–650. doi: 10.1046/j.1365-2036.2003.01456.x. - DOI - PubMed
    1. Bellini M., Gambaccini D., Stasi C., Urbano M.T., Marchi S., Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J. Gastroenterol. 2014;20:8807–8820. - PMC - PubMed
    1. Ford A.C., Forman D., Bailey A.G., Axon A.T.R., Moayyedi P. Irritable bowel syndrome: A 10-year natural history of symptoms, and factors that influence consultation behavior. Am. J. Gastroenterol. 2008;103:1229–1239. doi: 10.1111/j.1572-0241.2007.01740.x. - DOI - PubMed
    1. Carrasco-Labra A., Lytvyn L., Falck-Ytter Y., Surawicz C.M., Chey W.D. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D) Gastroenterology. 2019;157:859–880. doi: 10.1053/j.gastro.2019.06.014. - DOI - PubMed

Publication types

LinkOut - more resources